🇺🇸 FDA
Patent

US 12233166

Extended release compositions comprising pyridostigmine

granted A61KA61K31/4425A61K9/0065

Quick answer

US patent 12233166 (Extended release compositions comprising pyridostigmine) held by Amneal Complex Products Research LLC expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Amneal Complex Products Research LLC
Grant date
Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4425, A61K9/0065, A61K9/2846, A61K9/2866